Drug Profile
R 1484
Latest Information Update: 25 Jul 2006
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stress incontinence
Most Recent Events
- 25 Jul 2006 No development reported - Phase-I for Stress incontinence in USA (unspecified route)
- 17 Apr 2003 Phase-I clinical trials in Stress incontinence in USA (unspecified route)
- 17 Mar 2003 Preclinical trials in Stress incontinence in USA (unspecified route)